Phase 2 study met its primary endpoint, demonstrating statistically significant improved overall survival with elraglusib plus ...
The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...
News-Medical.Net on MSN
Digital coaching boosts asthma control and quality of life
While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
There are no FDA-approved therapies for the treatment of OI.
New peer-reviewed research adds to substantial body of scientific evidence highlighting the safety of natural kratom leaf ...
Background The global surge in ultra-processed food (UPF) consumption is a major public health challenge, particularly among ...
Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...
Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a ...
ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in psoriasis and quarterly ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback